Research Paper Volume 14, Issue 15 pp 6316—6337
SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer
Figure 5. Analysis of SAAL1 gene alterations and promoter methylation status in various cancer types. (A) SAAL1 gene alteration types and frequencies in different cancer types. (B) Mutation types, sites, and frequencies (case numbers). (C) Survival curves for cancer patients with and without altered SAAL1. (D) SAAL1 promoter methylation status in LUAD and LUSC.